Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis

References

• TorreLABrayFSiegelRLFerlayJLortet-tieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• YangMParkJYDNA methylation in promoter region as biomarkers in prostate cancerMethods Mol Biol20128636710922359288
   PubMedGoogle Scholar
• VelonasVMWooHHdos RemediosCGAssinderSJCurrent status of biomarkers for prostate cancerInt J Mol Sci2013146110341106023708103
   PubMed Web of Science ®Google Scholar
• SarkarSHornGMoultonKCancer development, progression, and therapy: an epigenetic overviewInt J Mol Sci20131410210872111324152442
   PubMed Web of Science ®Google Scholar
• SharmaSKellyTKJonesPAEpigenetics in cancerCarcinogenesis2009311273619752007
   PubMedGoogle Scholar
• TamWLWeinbergRAThe epigenetics of epithelial-mesenchymal plasticity in cancerNat Med20081445724732
   Google Scholar
• FeinbergAPKoldobskiyMAGöndörAEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionNat Rev Genet201617528429926972587
   PubMed Web of Science ®Google Scholar
• JonesPAIssaJ-PJBaylinSTargeting the cancer epigenome for therapyNat Rev Genet2016171063064127629931
   PubMed Web of Science ®Google Scholar
• ZhangLHuangYZhuoWZhuYZhuBChenZIdentification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancerMed Oncol2017345
   Google Scholar
• WeinsteinJNCollissonEAMillsGBThe cancer genome Atlas Pan-Cancer Analysis Project JohnNat Genet2014451011131120
   Google Scholar
• CotterillSJ homepage on the InternetCancer Genetics Web Available from: http://www.cancer-genetics.org/index.htmAccessed October 8, 2016
   Google Scholar
• HeXChangSZhangJMethyCancer: the database of human DNA methylation and cancerNucleic Acids Res200836suppl 1836841
   Google Scholar
• Tabas-madridDNogales-cadenasRPascual-montanoAGeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomicsNucleic Acids Res201240478483
   PubMed Web of Science ®Google Scholar
• MiHPoudelSMuruganujanACasagrandeJTThomasPDPANTHER version 10: expanded protein families and functions, and analysis toolsNucleic Acids Res201644D1D336D34226578592
   PubMed Web of Science ®Google Scholar
• KanehisaMGotoSKEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Res2000281273010592173
   PubMed Web of Science ®Google Scholar
• LopesCTFranzMKaziFDonaldsonSLMorrisQBaderGDCytoscape Web: an interactive web-based network browserBioinformatics2011271323472348
   Google Scholar
• JensenLJKuhnMStarkMSTRING 8 – a global view on proteins and their functional interactions in 630 organismsNucleic Acids Res200937suppl 1412416
   Google Scholar
• PongerLMouchiroudDCpGProD: identifying CpG islands associated with transcription start sites in large genomic mammalian sequencesBioinformatics200218463163312016061
   PubMedGoogle Scholar
• LiWCowleyAUludagMThe EMBL-EBI bioinformatics web and programmatic tools frameworkNucleic Acids Res201543580584
   PubMed Web of Science ®Google Scholar
• BaekSYangSKangTParkSSungYKimSMENT: methylation and expression database of normal and tumor tissuesGene2013518119420023219992
   PubMedGoogle Scholar
• ShiJHuJZhouQDuYJiangCPEpiD: a prostate epigenetic database in mammalsPLoS One201385e6428923696878
   PubMedGoogle Scholar
• AhmedHCappelloFRodolicoVEvidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer 1Transl Oncol20092314615619701499
   PubMed Web of Science ®Google Scholar
• SuhCIShanafeltTMayDJComparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancerMol Cell Probes200014421121710970725
   PubMedGoogle Scholar
• GoesslCKrauseHMuMSchraderMSachsingerJAdvances in brief fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluidsCancer Res20001559415945
   Google Scholar
• HardenSVGuoZEpsteinJISidranskyDQuantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinomaJ Urol200316931138114212576869
   PubMed Web of Science ®Google Scholar
• HardenSVGoodmanSNPartinAAWPatrickCEpsteinJIQuantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesJ Natl Cancer Inst200395211634163714600096
   PubMedGoogle Scholar
• GoesslCMuMKrauseHSchostakMStraubBMethylation-specific PCR for detection of neoplastic DNA in biopsy washingsJ Pathol2002196333133411857497
   PubMedGoogle Scholar
• TokumaruYHardenSVSunDYamashitaKEpsteinJISidranskyDOptimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinomaClin Cancer Res2004105518552215328191
   PubMedGoogle Scholar
• CairnsPEstellerMHermanJGMolecular detection of prostate cancer in urine by GSTP1 hypermethylation molecular detection of prostate cancer in urine by GSTP1Clin Cancer Res2001792727273011555585
   PubMedGoogle Scholar
• EllingerJBastianPJJurganTCpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancerUrology200871116116718242387
   PubMed Web of Science ®Google Scholar
• SunamiEShinozakiMHiganoCSMultimarker circulating DNA assay for assessing blood of prostate cancer patients methodsClin Chem2009567559567
   Google Scholar
• GonzalgoMLPavlovichCPLeeSMNelsonWGJamesTBradyBProstate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimensClin Cancer Res2003972673267712855646
   PubMed Web of Science ®Google Scholar
• RogersCGGonzalgoMLYanGHigh concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detectionJ Urol20061762280228417070312
   PubMed Web of Science ®Google Scholar
• HoqueMOTopalogluOBegumSHenriqueRRosenbaumEQuantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjectsJ Clin Oncol2015232765696575
   Google Scholar
• RouprêtMHupertanVYatesDRMolecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massageClin Cancer Res20071361720172517363525
   PubMed Web of Science ®Google Scholar
• MaruyamaRToyookaSToyookaKOAberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological featuresClin Cancer Res20028251451911839671
   PubMed Web of Science ®Google Scholar
• KangGHLeeSLeeHJHwangKSAberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasiaJ Pathol200420223324014743506
   PubMed Web of Science ®Google Scholar
• YamanakaMWatanabeMYamadaYAltered methylation of multiple genes in carcinogenesis of the prostateInt J Cancer2003106338238712845678
   PubMedGoogle Scholar
• GinsburgGSWilliardHFGenomic and Personalized MedicineAmsterdamAcademia Press2012
   Google Scholar
• JanGDecreased expression Of CD44 in metastatic prostate cancerInt J Cancer1999483478483
   Google Scholar
• AlumkalJJZhangZHumphreysEBBiomarkers and risk factors effect of DNA methylation on identification of aggressive prostate cancerUrology20087261234123918387661
   PubMedGoogle Scholar
• JarrardDFKinoshitaHShiYMethylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cellsCancer Res19985823531053159850055
   PubMed Web of Science ®Google Scholar
• KinoshitaHShiYSandefurCMethylation of the androgen receptor minimal promoter silences transcription in human prostate cancerCancer Res200060133623363010910077
   PubMedGoogle Scholar
• NakayamaTWatanabeMSuzukiHEpigenetic regulation of androgen receptor gene expression in human prostate cancersLab Invest200080121789179611140692
   PubMedGoogle Scholar
• SasakiMTanakaYPerincheryGMethylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancerJ Natl Cancer Inst200294538439011880477
   PubMed Web of Science ®Google Scholar
• JinBLiYRobertsonKDDNA methylation: superior or subordinate in the epigenetic hierarchy?Genes Cancer20112660761721941617
   PubMedGoogle Scholar
• LawJAJacobsenSEEstablishing, maintaining and modifying DNA methylation patterns in plants and animals JulieNat Rev Genet2011113204220
   Google Scholar
• BonelliPTuccilloFMBorrelliASchiattarellaABuonaguroFMCDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivityBiomed Res Int2014201436102024605326
   PubMed Web of Science ®Google Scholar
• NguyenTTNguyenCTGonzalesFANicholsPWYuMCJonesPAAnalysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancersProstate200043323324210797499
   PubMedGoogle Scholar
• HermanGMerloAMaoLInactivation of the CDKN2/p16/MTSJ gene is frequently associated with aberrant DNA methylation in all common human cancers’Cancer Res19957145254530
   Google Scholar
• MusgroveEACaldonCEBarracloughJStoneASutherlandRLCyclin D as a therapeutic target in cancerNat Rev Cancer201111855857221734724
   PubMed Web of Science ®Google Scholar
• VerkaikNSvan SteenbruggeGJvan WeerdenWMBussemakersMJvan der KwastTHSilencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter regionLab Invest20008081291129810950120
   PubMedGoogle Scholar
• ZhengJXiongDSunXSignification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progressionCancer Microenviron20121285293
   Google Scholar
• WoodsonKO’ReillyKJWardDECD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized diseaseEpigenetics20061418318617998819
   PubMed Web of Science ®Google Scholar
• LodyginDHermekingHThe role of epigenetic inactivation of 14-3-3 σ in human cancerCell Res200515423724615857578
   PubMedGoogle Scholar
• MichieAMMccaigAMNakagawaRVukovicMDeath-associated protein kinase (DAPK) and signal transduction: regulation in cancerFEBS J20102771748019878310
   PubMedGoogle Scholar
• FournierGCussenotOPescheSLatilABieILidereauRMolecular analysis of the FHIT gene in human prostate cancerOncogene19981614186318689583683
   PubMedGoogle Scholar
• PaoMMTsutsumiMLiangGUzvolgyiEGonzalesFAJonesPAThe endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cellsHum Mol Genet200110990391011309363
   PubMedGoogle Scholar
• MohammadiNBabashahSInterplay between microRNAs and WNT/b -catenin signalling pathway regulates epithelial – mesenchymal transition in cancerEur J Cancer201551121638164926025765
   PubMedGoogle Scholar
• ZhanTRindtorffNBoutrosMWnt signaling in cancerOncogene201736111461147327617575
   PubMed Web of Science ®Google Scholar
• OsmanIDrobnjakMFazzariMFerraraJScherHICordon-CardoCInactivation of the p53 pathway in prostate cancer: impact on tumor progressionClin Cancer Res1999582082208810473090
   PubMedGoogle Scholar
• CronauerMVSchulzWABurchardtTAckermannRBurchardtMInhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell linesOncogene200423203541354915077179
   PubMedGoogle Scholar
• SteghAHTargeting the p53 signaling pathway in cancer therapyExpert Opin Ther Targets2012161678322239435
   PubMed Web of Science ®Google Scholar
• MassieCEMillsIGLynchAGThe importance of DNA methylation in prostate cancer developmentJ Steroid Biochem Mol Biol201616611527117390
   PubMedGoogle Scholar
• TanHSoodARahimiHARb loss is characteristic of prostatic small cell neuroendocrine carcinoma Rb loss is characteristic of prostatic small cellClin Cancer Res201420489090324323898
   PubMed Web of Science ®Google Scholar
• KinoshitaHShiYSandefurCMethylation of the androgen receptor minimal promoter silences transcription in human prostate cancerCancer Res200060133623363010910077
   PubMedGoogle Scholar
• GravinaGLMaramponFDi StasoM5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient Prostate tumorsProstate2010117811661178
   Google Scholar
• GravinaGLFestucciaCMillimaggiDChronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cellsProstate200868779380118324645
   PubMedGoogle Scholar
• ZornCSWojnoKJMccabeMTKueferRGschwendJEDayMLCancer therapy: preclinical 5-Aza-2′-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancerClin Cancer Res20071372136214417404097
   PubMedGoogle Scholar
• AndreevaAVKutuzovMACadherin 13 in cancerGenes Chromosomes Cancer201049977579020607704
   PubMed Web of Science ®Google Scholar
• MartignanoFGurioliGSalviSGSTP1 methylation and protein expression in prostate cancer: diagnostic implicationsDis Markers2016201616
   Google Scholar
• LiuLYoonJDammannRPfeiferGPFrequent hypermethylation of the RASSF1A gene in prostate cancerOncogene2002216835684012360410
   PubMed Web of Science ®Google Scholar